TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
What to Make of Canopy Growth Corp.’s Latest Earnings Report

Investing
Why Marijuana Companies Belong (or Don’t) in Your RRSP
Investing
Cannabis Investors: Cronos Group Inc. Hits the NASDAQ: Time to Buy?

Investing
Canopy Growth Corp. Is Down 33%: Time to Buy?
Investing
Top 3 Monster Growth Stocks to Add to Your RRSP

Investing
Bitcoin Faces Another Hurdle
Investing
Legal Cannabis Delay: Does it Make Any Difference for Pot Stocks?
Investing
Marijuana Investors: Is the Sky-High Legalization Demand for Cannabis Just a Hallucination?

Dividend Stocks
3 Stocks That Will Save You Next Time the Market Crashes

Investing
Have Pot Stocks Finally Run Out of Steam?

Investing
Canopy Growth Corp.: Why its Stock Surged 11% Yesterday
